About This Desk

What EpiPure Peptides is

EpiPure Peptides is an independent editorial reference desk covering four research peptides — ipamorelin, KPV, tesamorelin, and tirzepatide — that share a category (research peptides studied for tissue repair, the growth-hormone axis, metabolic, and inflammatory outcomes) without sharing a mechanism, an evidence base, or a regulatory status. The desk exists because the marketing built around these compounds routinely erases exactly the distinctions that matter: whether a claim comes from a large human trial, a single small study, a mouse model, or a forum post.

The organizing discipline here is skepticism applied evenly. Before describing what a compound does, every page on this site first establishes how solid the underlying evidence actually is, and separately, whether material obtainable outside a clinical trial or pharmacy has any verified relationship to what was studied. Those two questions — evidence quality and sourcing integrity — are asked of tirzepatide, the best-evidenced compound here, with the same rigor applied to KPV, which has no human trial at all. Consistency of scrutiny, not uniformity of conclusion, is the standard.

How it is compiled

Three principles govern what appears on this site.

First, every factual claim is tied to a specific, checkable source. Citations are numbered and collected on the references page, with DOIs and PubMed links wherever they exist. Claims that come from a review rather than a primary study are described as such; claims from a preclinical model are never presented as if they were clinical findings.

Second, the strength of a finding is stated, not implied. A single negative human trial ^[3] is described as exactly that, not smoothed over with a compound's broader reputation. A meta-analysis that clears one safety concern while confirming a different one ^[20] is reported with both halves intact, not reduced to a single headline. Where the honest answer is that no human data exists, this desk says so directly, as it does for KPV.

Third, community-reported effects are labeled as anecdotal, always. Where real_world community reports exist in the source material, they are rendered with the explicit label "anecdotal, not clinical evidence" and never attached to a specific dose or sourcing recommendation. Where no such reports were compiled for a compound, this desk states that plainly rather than inventing a plausible-sounding paragraph.

What it is not

EpiPure Peptides is not a pharmacy, a clinic, a telehealth service, or a vendor of any research chemical or medicine. It does not sell, source, broker, or recommend any supplier, and it has no affiliate or referral relationship with any manufacturer, compounding pharmacy, or research-chemical seller. It does not diagnose, prescribe, or recommend a dose, schedule, or route of administration for any person.

Tesamorelin and tirzepatide are approved prescription medicines available only through licensed medical providers, for their approved indications. Ipamorelin and KPV are not approved for any human use anywhere and are sold strictly as research chemicals; nothing on this site should be read as encouragement to use them outside a research context. Readers seeking clinical guidance should consult a licensed healthcare provider in their own jurisdiction. Editorial correspondence regarding citations, corrections, or newly published research can be directed to the contact page; this desk monitors that correspondence but cannot respond to requests for medical advice.